Interview with the CEO of VIDA, one of the top companies recognized within the healthcare imagery category.
1:04: What does VIDA do?
1:35: What is the backstory of VIDA?
2:47: When would providers use VIDA?
4:58: Why are CT scans used for respiratory exams?
6:28: What did providers do without VIDA?
8:43: Can you share more details about your patent on visualizing lungs?
10:33: How did you build your platform’s functionality?
13:44: How much assistance does your AI solution provide?
17:41: Can you talk about your supporting services that you offer to your customers?
22:09: Are there limitations or risks using your platform?
25:37: How do you implement VIDA?
28:54: How do you manage long sales cycles?
30:50: How has the pandemic affected your company?
36:36: What is the future of healthcare imagery services?
39:16: Closing remarks
About VIDA: VIDA provides AI-powered chest CT analysis to profile/manage a patient with, or at-risk of, respiratory diseases. Their software automatically quantifies lung density and visualizes airways. They do this using a topographic MPR technique that samples/projects many non-overlapping airways onto a single image. This method delivers global airway information, at higher resolution, without losing context to the surrounding tissue. Their platform also provides per-procedural pat planning, intra-procedural guidance (virtual bronchoscopy), lung cancer resection (LCR) evaluations and lung volume analysis reports. Visit: vidalung.ai
